-
Je něco špatně v tomto záznamu ?
A rat model of early sepsis: relationships between gentamicin pharmacokinetics and systemic and renal effects of bacterial lipopolysaccharide combined with interleukin-2
S. Studena, J. Martinkova, D. Slizova, O. Krs, M. Senkerik, D. Springer, J. Chládek,
Jazyk angličtina Země Japonsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1993
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
od 1993
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
od 1993
Open Access Digital Library
od 1993-01-01
PubMed
23037160
DOI
10.1248/bpb.b12-00205
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky krev farmakokinetika moč MeSH
- gentamiciny krev farmakokinetika moč MeSH
- hodnoty glomerulární filtrace účinky léků MeSH
- interleukin-2 aplikace a dávkování MeSH
- kapilární permeabilita účinky léků MeSH
- krysa rodu rattus MeSH
- ledviny účinky léků metabolismus patofyziologie MeSH
- lipopolysacharidy aplikace a dávkování MeSH
- modely nemocí na zvířatech * MeSH
- potkani Wistar MeSH
- sepse metabolismus patofyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A rat model of early sepsis induced by lipopolysaccharide (LPS) combined with interleukin-2 (IL-2) was developed. The primary aim was to assess the pharmacokinetics of gentamicin and sepsis-induced pathophysiological changes. Moreover, the effects on the glomerular filtration rate and tubular function were studied in septic and control rats. First, an intravenous (i.v.) bolus of LPSIL-2 (1 mg/kg-Pseudomonas aeruginosa, 15 µg/kg IL-2) or saline (controls, C) was administred. The Wistar rats were treated 30 min after LPSIL-2 with gentamicin as a 3 mg/kg i.v. bolus followed 10 min later by an i.v. 170-min infusion (GE, 0.09 mg/kg·min(-1)). The monitoring of vital functions, biochemistry and GE concentrations was performed. Creatinine clearance was 2-3 times lower and fractional urea excretion was 3-4 times less in septic rats as compared to controls(p<0.05), although urine flow was comparable. Capillary leakage caused a 55% elevation in the volume of distribution (V(c)) in the LPSIL+GE group vs. C+GE (p<0.05). The renal CL(ge) was less (2.2±0.59 vs. 3.8±0.53 mL/min·kg(-1), p<0.05), while the total CL(ge) was comparable (5.9±1.5 vs. 6.7±1.1 mL/min·kg(-1); p=0.30). In the LPSIL+GE group relative to C+GE, the half-life (t(1/2)) was 79% higher (p<0.05) and GE concentrations detected at the end of the study in the plasma and kidney were elevated 2.5-fold (p=0.09) and 2.2-fold (p<0.05), respectively. The model reproduced several consequences of early sepsis like in patients such as capillary leak, a decreased glomerular filtration rate (GFR) and the changes in pharmacokinetics of GE (increased values of V(c) and t(1/2) and a drop in renal CL(ge) proportional to that of CL(cr)). Nonrenal routes which, for the most part, compensate the reduced renal CL(ge) in septic rats deserve further study.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012407
- 003
- CZ-PrNML
- 005
- 20130410094012.0
- 007
- ta
- 008
- 130404s2012 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1248/bpb.b12-00205 $2 doi
- 035 __
- $a (PubMed)23037160
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Studena, Sarka $u Department of Pharmacology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Czech Republic.
- 245 12
- $a A rat model of early sepsis: relationships between gentamicin pharmacokinetics and systemic and renal effects of bacterial lipopolysaccharide combined with interleukin-2 / $c S. Studena, J. Martinkova, D. Slizova, O. Krs, M. Senkerik, D. Springer, J. Chládek,
- 520 9_
- $a A rat model of early sepsis induced by lipopolysaccharide (LPS) combined with interleukin-2 (IL-2) was developed. The primary aim was to assess the pharmacokinetics of gentamicin and sepsis-induced pathophysiological changes. Moreover, the effects on the glomerular filtration rate and tubular function were studied in septic and control rats. First, an intravenous (i.v.) bolus of LPSIL-2 (1 mg/kg-Pseudomonas aeruginosa, 15 µg/kg IL-2) or saline (controls, C) was administred. The Wistar rats were treated 30 min after LPSIL-2 with gentamicin as a 3 mg/kg i.v. bolus followed 10 min later by an i.v. 170-min infusion (GE, 0.09 mg/kg·min(-1)). The monitoring of vital functions, biochemistry and GE concentrations was performed. Creatinine clearance was 2-3 times lower and fractional urea excretion was 3-4 times less in septic rats as compared to controls(p<0.05), although urine flow was comparable. Capillary leakage caused a 55% elevation in the volume of distribution (V(c)) in the LPSIL+GE group vs. C+GE (p<0.05). The renal CL(ge) was less (2.2±0.59 vs. 3.8±0.53 mL/min·kg(-1), p<0.05), while the total CL(ge) was comparable (5.9±1.5 vs. 6.7±1.1 mL/min·kg(-1); p=0.30). In the LPSIL+GE group relative to C+GE, the half-life (t(1/2)) was 79% higher (p<0.05) and GE concentrations detected at the end of the study in the plasma and kidney were elevated 2.5-fold (p=0.09) and 2.2-fold (p<0.05), respectively. The model reproduced several consequences of early sepsis like in patients such as capillary leak, a decreased glomerular filtration rate (GFR) and the changes in pharmacokinetics of GE (increased values of V(c) and t(1/2) and a drop in renal CL(ge) proportional to that of CL(cr)). Nonrenal routes which, for the most part, compensate the reduced renal CL(ge) in septic rats deserve further study.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x krev $x farmakokinetika $x moč $7 D000900
- 650 _2
- $a kapilární permeabilita $x účinky léků $7 D002199
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a gentamiciny $x krev $x farmakokinetika $x moč $7 D005839
- 650 _2
- $a hodnoty glomerulární filtrace $x účinky léků $7 D005919
- 650 _2
- $a interleukin-2 $x aplikace a dávkování $7 D007376
- 650 _2
- $a ledviny $x účinky léků $x metabolismus $x patofyziologie $7 D007668
- 650 _2
- $a lipopolysacharidy $x aplikace a dávkování $7 D008070
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a sepse $x metabolismus $x patofyziologie $7 D018805
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Martinkova, Jirina $u -
- 700 1_
- $a Slizova, Dasa $u -
- 700 1_
- $a Krs, Otakar $u -
- 700 1_
- $a Senkerik, Marian $u -
- 700 1_
- $a Springer, Drahomira $u -
- 700 1_
- $a Chládek, Jaroslav $u -
- 773 0_
- $w MED00000729 $t Biological & pharmaceutical bulletin $x 1347-5215 $g Roč. 35, č. 10 (2012), s. 1703-10
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23037160 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130410094241 $b ABA008
- 999 __
- $a ok $b bmc $g 975605 $s 810688
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 35 $c 10 $d 1703-10 $i 1347-5215 $m Biological & pharmaceutical bulletin $n Biol Pharm Bull $x MED00000729
- LZP __
- $a Pubmed-20130404